Visiongain Publishes Powered Surgical Instruments Market Report 2020-2030

30 July 2020
Pharma

Visiongain has launched a new report Powered Surgical Instruments Market Report 2020-2030: Forecasts by Power Source (Electric Instruments, Battery-powered Instruments, Pneumatic Instruments), Product (Handpieces, Power Source and Controls, Accessories), Application (Orthopedic Surgery, Oral and Maxillofacial Surgery, ENT Surgery, Neurosurgery, Plastic and Reconstructive Surgery, Cardiothoracic Surgery), and by Region (North America, Europe, Asia Pacific, Latin America & MEA), Including Forecasts by Major Developed Countries and Developing Countries, Plus Profiles of Leading Companies.

Powered surgical instruments are used for surgical procedures for various purposes such as sculpting and precision drilling. These instruments can be powered using different sources such as electrical, pneumatic, and battery. The advancement in robotic surgeries will help to increase the demand for powered surgical instruments in the near future. Handpiece instruments is the largest contributor towards the powered surgical instruments market owing to the favourable features such as ease of use, better efficiency and power, and lightweight frames. Powered surgical instruments are commonly used for orthopaedic surgical procedures owing to the rise in elderly population and increase in prevalence of bone diseases.

According to WHO, the geriatric population is expected to increase to 16% of the global population by 2050 as compared to 7% of the global population that were above 65 years in 2000. The geriatric population are more prone to suffer from orthopaedic and cardiovascular related surgical procedures. The increase in geriatric population will increase the demand for these devices. According to a report by American Society of Plastic Surgeons, the number of minimally invasive procedures had increased by 2% in 2017 accounting for around 17 million as compared to 2016. Minimally invasive procedures require the use of devices that help in performing surgeries with precision. As powered surgical instruments are help surgeons manoeuvre the devices better and improve efficiency, the increase in these procedures help to increase the use of powered surgical procedures.

The rise in medical tourism in developing countries, increase in healthcare expenditure, rise in incidence of chronic diseases, and surgeons preference to use advanced powered surgical device further drives the growth of global powered surgical instruments market. However, the high cost of these devices and lack of skilled professionals are expected to hamper the market growth.

The Visiongain report analyst commented “The rise in the geriatric population, increase in incidence of chronic diseases, and rise in the number of surgical procedures conducted globally are the key factors boosting the growth of powered surgical instruments market. Moreover, the rise in medical tourism and market opportunities available in developing countries will help to further drive the market growth.”

The report covers a detailed competitive outlook that includes market share and company profiles of key players operating in the global market. Key players profiled in the report include Stryker Corporation, Zimmer Biomet, adeor Medical AG, AlloTech Co. Ltd., Conmed Corporation, Depuy Synthes, Medtronic plc, Smith & Nephew plc, B. Braun Melsungen AG, and MicroAire Surgical Instruments, LLC.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031

We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

29 July 2021

Read

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

Read

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

Read

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever